← BackADMA BIOLOGICS, INC. · BiotechADMA
Low riskNext report: Around Nov 4 (est.)
The short versionA profitable company with steady sales. Institutions are trimming.
Going well
- Profitable, keeps 29% of sales as profit
- Sales up 20% last year
- Brings in more cash than it spends
Watch out for
- Share count growing 7.4% a year
Money moves
- No insider buying or selling in the last 30 days
- Institutions cut 3% from their holdings in the quarter ending June 2026 (138 bought, 231 sold)
- Held by Ray Dalio (Bridgewater), Stanley Druckenmiller (Duquesne), Terry Smith (Fundsmith)
Facts from SEC filings, not a recommendation.
What the price means
Price as of Oct 26
$11.07+3.6% that day
- Company value
- $2.5B
- Share price times all shares
- Price vs profit (P/E)
- 15.8x
- You pay about $16 for each $1 of yearly profit
- Price vs sales
- 4.8x
- Company value is 4.8 times a year of sales
- Cash vs value
- 5%
- Cash as a share of company value
- Debt vs value
- 3%
- Debt as a share of company value
From ADMA's last IEX trade and its SEC filings (profits and sales over the last four quarters). A starting point for research, not a verdict.
The business over time
Last 12 quarters, from SEC filings
Sales, Jun '26$124.4M+2.0% vs a year earlier
Sep '23Tap a barJun '26
Last 12 months: $512.3M, up 8.0% from the 12 months before. Over 5 years, sales grew about 65% a year.
Business quality
The checklist Warren Buffett-style investors use. Annual numbers for 2025.- PassReturn on equity 15%+Earns a lot on the money owners have in the business.35.6%
- PassDebt under half of equityNot relying on borrowed money.0.15x equity
- PassNet margin 10%+Keeps at least 10 cents of profit from each dollar of sales.28.8%
- MissProfitable every yearSteady profits, not one good year.2 of 10 years
- PassFree cash flow positiveBrings in more cash than it spends to run and grow.$27.8M
- MissShare count not growingNot diluting owners. Falling means buybacks.+23.8% in 3 years
- PassGross margin 40%+Pricing power: sells for well above what it costs to make.57.4%
- Revenue
- $510.2M
- +19.6% vs prior year
- 5-year growth
- +64.6%/yr
- revenue, per year
- Total debt
- $72.1M
- 0.15x equity
- Current ratio
- 6.71x
- short-term assets / bills due
From annual reports filed with the SEC. A checklist is a starting point for research, not a verdict.
Latest quarter
Quarter ended Jun 30, 2026- Revenue
- $124.4M
- +2.0% YoY
- EPS
- $0.16
- vs $0.14
- Op. margin
- 42.2%
- +7.1 pts
- Gross margin
- 69.4%
- +14.3 pts
- Free cash flow
- $27.3M
- Share count
- -7.3%
- vs a year ago
Insider rating
Last 90 days
No open-market insider buys or sells in the last 90 days.
Weekly insider trendNo trades to chart yet.
Filing buzz
Last 7 days vs normal
0/ 100
- This week
- 0
- Normal week
- 0.3
- vs normal
- 0.0x
SEC filings of any kind. 50 means a normal week.
Institutional ownership
▼Distributing-3.0%Institutions cut 3.0% from their holdings. 138 bought, 231 sold. 3 quarters of net selling in a row.
Shares held by institutions205.7M
Sep '24Jun '26
Share count growthYearly rate, last 3 years
-0.1%Cash runwayAt last year's cash burn
Cash flow positiveDebt to equityLatest balance sheet: debt compared with what owners have
0.5x · $196.6M debtShares outstandingLatest reported
224MNext reportAround Nov 4 (est.)Estimated from the same quarter last year
- Results filedAug 5
- Results filedMay 6
- Results filedFeb 25
- Results filedJan 12
- Results filedNov 5, 2025
Insider trades
Open-market buys and sells, last 90 days
No open-market buys or sells in 90 days. Grants and option exercises are left out.
"Owns after" is the insider's holding right after the trade. Pre-planned (10b5-1) sales are set up months ahead, a weaker signal.
Latest filings
Straight from SEC EDGAR
Shares withheld for taxesKaitlin M. Kestenberg-messinaCOO and SVP, Compliance
3,177 shares at $8.37 · $27K
- -1% of holdings
- Now owns 443,061 shares
- Filed 4 days after trade
Stock awardTerry KohlerCFO and Treasurer
85,130 shares
- +147% of holdings
- Now owns 143,149 shares
- Exercise price $8.81
- Filed 1 day after trade
BoughtJerrold B GrossmanDirector
6,400 shares at $7.91 · $51K
- +1% of holdings
- Now owns 520,284 shares
- Filed 1 day after trade
BoughtJerrold B GrossmanDirector
12,500 shares at $8.01 · $100K
- +2% of holdings
- Now owns 513,884 shares
- Filed 2 days after trade
BoughtJerrold B GrossmanDirector
12,500 shares at $8.01 · $100K
- +3% of holdings
- Now owns 501,384 shares
- Filed 1 day after trade